Description: This session explores the issues raised and logistical problems encountered in setting risk-based capital RBC factors for various health products. Also discussed is the development of surplus requriements for disability income products. From the Record of the Society of Actuaries, Volume 27, No. 1, Session 95

Description: This session discusses how many carriers use simplified underwriting techniques or alternative underwriting approaches to streamline the underwriting/policy issue process. From the Record of the Society of Actuaries, Volume 27, No. 3, Session 130

Description: This paper describes an actuarial methodology for evaluating disease management outcomes. We address several important issues in this paper: • Control of exposure, • Identification of measured populations, and • Ensuring equivalence between baseline and intervention populations. - Paper 6 of an 8 paper series on 'An Introduction to Care Management Interventions and Their Implications for Actuaries'.

Description: Panelists discuss the different aspects of contract reserves for medical products under both the statutory and the GAAP requirements. Session 23PD of the 2005 Valuation Actuary Symposium.

Description: Features of Critical Illness products

Description: Analysis of diagnosis and pharmacy-based methods of health risk assessment. Issue No. 44.

Description: Applying Diagnosis-Based Predictive Models that use medical and pharmacy claims to measure expected costs for Group Underwriting. Issue No. 46.

Description: We highlight a new approach leveraging predictive analytics to identify high risk and rising risk opioid users for more effective screening and follow-up care.

Description: This session presents a summary of actuarial and potential uses of stochastic modeling for health actuaries. Three case studies are presented: rating health plan reimbursement provisions, developing claim liabilities, and defining appropriate reinsurance levels. From the Record of the Society of Actuaries, Volume 30, No. 1, Session 18

Description: Presented at June 1996 Spring Meeting. This discussion looks at how a managed care plan can know whether it is doing a good job on utilization review, if there is room for further reduction in utilization, and how a plan should prevent under-utilization.